HOME >> BIOLOGY >> NEWS
UC San Diego undergraduates do cyberinfrastructure research in Asia, Australia

June 17, 2005

UCSD Undergraduates Selected to Research Cyberinfrastructure at Pacific Rim Universities

A unique summer program that allows University of California, San Diego undergraduate students to do hands-on, information-technology research in Asia is expanding this year from three to four host countries, and the program is drawing more female students.

Thirteen students - five of them women - fly next week from the United States to their respective host sites in Australia, Japan, Taiwan and China, the newest site. The students are part of a pilot program at UCSD called Pacific Rim Undergraduate Experiences (PRIME), launched in 2004 to encourage global experiences for students doing research related to the global cyberinfrastructure.

Many of this year's recruits were introduced to the program by word-of-mouth. Shirley Lee is headed for Taiwan. "I heard about the PRIME program through a friend who participated in it last summer," said Lee, a biotechnology major in UCSD's Jacobs School of Engineering, Class of '06. "We volunteer in the same bioengineering lab, so I was able to learn about his experiences in Osaka, Japan last summer."

"That is a very encouraging sign," concluded Gabriele Wienhausen, provost of UCSD's Sixth College and PRIME's principal investigator. "It shows that last year's students came away with very positive experiences from working alongside researchers in labs where the language and customs may be very different."

PRIME is supported by a grant from NSF (NSF INT 0407508) and from the California Institute for Telecommunications and Information Technology (Calit2). It is a partnership of Sixth College, UCSD's Academic Internship Program (AIP), the Pacific Rim Applications and Grid Middleware Assembly (PRAGMA), and the host institutions in Asia and Australia (see below).

In recent weeks, the PRIME students attended a series of meetings designed to give them a crash course in living and wor
'"/>

Contact: Doug Ramsey
dramsey@ucsd.edu
858-822-5825
University of California - San Diego
17-Jun-2005


Page: 1 2 3 4 5 6

Related biology news :

1. Revelle family endows UC San Diego chair honoring Roger Revelle
2. Ocean observing contracts awarded to UC San Diego and University of Washington
3. Latest plant health research to be presented in San Diego
4. UC San Diego supercomputer simulations may pinpoint causes of Parkinsons, Alzheimers diseases
5. San Diego stem cell consortium tops in state funding
6. University of Colorado influenza chip licensed by Quidel Corp. of San Diego
7. University of California, San Diego-led team discovers how we detect sour taste
8. Burnham Institute for Medical Research & UC San Diego establish Joint Center for Molecular Modeling
9. UC San Diego biologists solve plant growth hormone enigma
10. UC San Diego scientists chart rapid advances of fluorescent tools for life-science research
11. UC San Diego partners with Venter Institute to build marine microbial genomics cyberinfrastructure

Post Your Comments:
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: